They showed a mean weight loss of 5.8-7.0 kg after 6 months
It was released as a blood glucose control treatment for patients with diabetes, but it was approved for use as an obesity treatment by the US Food and Drug Administration (FDA) in 2014, as it was found to be effective for weight loss without hypoglycemia in obese people who did not have diabetes
Unlike the full-length growth hormone, AOD9604 retains the lipolytic (fat-mobilizing) and anti-lipogenic (fat-inhibiting) properties of hGH, while importantly lacking its proliferative effects (e.g., on glucose levels, IGF-1 production, or cell proliferation)
Best Stack for Fat Loss Fat loss peptide stacks divide into two categories: GLP-1 receptor agonist stacks (semaglutide, tirzepatide) that suppress appetite through incretin signaling, and metabolic peptide stacks (MOTS-c, tesamorelin) that increase energy expenditure or target specific fat deposits